Marshall Williams

Dr. Marshall Williams

The Ohio State University Wexner Medical Center

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1997 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
GBGautam N. Bijur
Gautam N. Bijur
MAMaria E. Ariza
Maria E. Ariza
CHCharles L. Hitchcock
Charles L. Hitchcock
MWMarshall Williams
Marshall Williams

24 March 1999 in Environmental and Molecular Mutagenesis
Verified
Journal Article
Closed access
PDF file
GBGautam N. Bijur
Gautam N. Bijur
BBBruce Briggs
Bruce Briggs
CHCharles L. Hitchcock
Charles L. Hitchcock
MWMarshall Williams
Marshall Williams

28 January 1999 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Closed access
PDF file
MAMaria E. Ariza
Maria E. Ariza
MWMarshall Williams
Marshall Williams

28 December 2016 in Pathogens
Verified
Journal Article
Open access
PDF file
MWMarshall Williams
Marshall Williams
BCBrandon Cox
Brandon Cox
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
The human herpesviruses are ubiquitous viruses and have a prevalence of over 90% in the adult population. Following a primary infection they establish latency and can be reactivated over a person’s lifetime. While it is well accepted that human herpesviruses are implicated in numerous diseases ranging from dermatological and autoimmune disease to cancer, the role of lytic proteins in the pathophysiology of herpesvirus-associated diseases remains largely understudies. Only recently have we begun to appreciate the importance of lytic proteins produced during reactivation of the virus, in particular the deoxyuridine triphosphate nucleotidohydrolases (dUTPase), as key modulators of the host innate and adaptive immune responses. In this review, we provide evidence from animal and human studies of the Epstein–Barr virus as a prototype, supporting the notion that herpesviruses dUTPases are a family of proteins with unique immunoregulatory functions that can alter the inflammatory microenvironment and thus exacerbate the immune pathology of herpesvirus-related diseases including myalgic encephalomyelitis/chronic fatigue syndrome, autoimmune diseases, and cancer.

28 January 2022 in Biomolecules
Verified
Journal Article
Open access
PDF file
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
BCBrandon Cox
Brandon Cox
BMBritney Martinez
Britney Martinez
IMIrene Mena-Palomo Irene Mena-Palomo
Irene Mena-Palomo Irene Mena-Palomo
Gloria Jerónimo ZárateGloria Jerónimo Zárate
Gloria Jerónimo Zárate
MWMarshall Williams
Marshall Williams
Most free-living organisms encode for a deoxyuridine triphosphate nucleotidohydrolase (dUTPase; EC 3.6.1.23). dUTPases represent a family of metalloenzymes that catalyze the hydrolysis of dUTP to dUMP and pyrophosphate, preventing dUTP from being incorporated into DNA by DNA polymerases, maintaining a low dUTP/dTTP pool ratio and providing a necessary precursor for dTTP biosynthesis. Thus, dUTPases are involved in maintaining genomic integrity by preventing the uracilation of DNA. Many DNA-containing viruses, which infect mammals also encode for a dUTPase. This review will summarize studies demonstrating that, in addition to their classical enzymatic activity, some dUTPases possess novel functions that modulate the host innate immune response.

1 May 2018 in Cancers
Verified
Journal Article
Open access
PDF file
MWMarshall Williams
Marshall Williams
Maria Eugenia ArizaMaria Eugenia Ariza
Maria Eugenia Ariza
The Epstein-Barr virus (EBV), which is a ubiquitous γ-herpesvirus, establishes a latent infection in more than 90% of the global adult population. EBV-associated malignancies have increased by 14.6% over the last 20 years, and account for approximately 1.5% of all cancers worldwide and 1.8% of all cancer deaths. However, the potential involvement/contribution of lytic proteins to the pathophysiology of EBV-associated cancers is not well understood. We have previously demonstrated that the EBV-deoxyuridine triphosphate nucleotidohydrolase (dUTPase) modulates innate and adaptive immune responses by engaging the Toll-Like Receptor 2 (TLR2), which leads to the modulation of downstream genes involved in oncogenesis, chronic inflammation, and in effector T-cell function. Furthermore, examination of serum samples from diffuse large B-cell lymphoma (DLBCL) and chronic lymphocytic leukemia patients revealed the presence of increased levels of anti-dUTPase antibodies in both cohorts compared to controls with the highest levels (3.67-fold increase) observed in DLBCL female cases and the lowest (2.12-fold increase) in DLBCL males. Using computer-generated algorithms, dUTPase amino acid sequence alignments, and functional studies of BLLF3 mutants, we identified a putative amino acid motif involved with TLR2 interaction. These findings suggest that the EBV-dUTPase: TLR2 interaction is a potential molecular target that could be used for developing novel therapeutics (small molecules/vaccines).